TW370529B
(en)
*
|
1992-12-17 |
1999-09-21 |
Pfizer |
Pyrazolopyrimidines
|
CZ101496A3
(en)
*
|
1993-10-12 |
1996-11-13 |
Du Pont Merck Pharma |
N-alkyl-n-aryl-pyrimidinamines and derivatives thereof
|
IL112249A
(en)
*
|
1994-01-25 |
2001-11-25 |
Warner Lambert Co |
Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
|
US5679683A
(en)
*
|
1994-01-25 |
1997-10-21 |
Warner-Lambert Company |
Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
|
IL112248A0
(en)
|
1994-01-25 |
1995-03-30 |
Warner Lambert Co |
Tricyclic heteroaromatic compounds and pharmaceutical compositions containing them
|
MX9605218A
(es)
*
|
1994-04-29 |
1997-10-31 |
Pfizer |
Amidas aciclicas y ciclicas novedosas como mejoradores de liberacion de neurotransmisores.
|
FR2719587B1
(fr)
*
|
1994-05-03 |
1996-07-12 |
Roussel Uclaf |
Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
|
TW574214B
(en)
*
|
1994-06-08 |
2004-02-01 |
Pfizer |
Corticotropin releasing factor antagonists
|
US5646152A
(en)
*
|
1994-06-15 |
1997-07-08 |
Pfizer Inc. |
Methods of administering CRF antagonists
|
CZ287613B6
(en)
*
|
1994-06-16 |
2001-01-17 |
Pfizer |
Pyrazolo- and pyrrolopyridines and pharmaceutical preparations based thereon
|
EP0729758A3
(fr)
*
|
1995-03-02 |
1997-10-29 |
Pfizer |
Pyrazolopyrimidines et pyrrolopyrimidines pour traiter les troubles neuronaux et autres maladies
|
US5593997A
(en)
*
|
1995-05-23 |
1997-01-14 |
Pfizer Inc. |
4-aminopyrazolo(3-,4-D)pyrimidine and 4-aminopyrazolo-(3,4-D)pyridine tyrosine kinase inhibitors
|
US7067664B1
(en)
|
1995-06-06 |
2006-06-27 |
Pfizer Inc. |
Corticotropin releasing factor antagonists
|
US6403599B1
(en)
*
|
1995-11-08 |
2002-06-11 |
Pfizer Inc |
Corticotropin releasing factor antagonists
|
US5747495A
(en)
*
|
1995-08-22 |
1998-05-05 |
Hiroshi Maeda |
Method for treating hypertension using pyrazolopyrimidine derivatives
|
EP0778277B1
(fr)
*
|
1995-12-08 |
2003-06-25 |
Pfizer Inc. |
Derivés hétérocycliques substitués comme CRF antagonistes
|
US6992188B1
(en)
|
1995-12-08 |
2006-01-31 |
Pfizer, Inc. |
Substituted heterocyclic derivatives
|
PL191271B1
(pl)
*
|
1996-02-07 |
2006-04-28 |
Neurocrine Biosciences Inc |
Pochodna pirazolopirymidyny i jej zastosowanie oraz kompozycja farmaceutyczna
|
US6664261B2
(en)
|
1996-02-07 |
2003-12-16 |
Neurocrine Biosciences, Inc. |
Pyrazolopyrimidines as CRF receptor antagonists
|
KR19990067390A
(ko)
|
1996-02-07 |
1999-08-16 |
뉴로크린 바이오사이언시즈 인코퍼레이티드 |
티오페노피리미딘
|
US6051578A
(en)
*
|
1996-02-12 |
2000-04-18 |
Pfizer Inc. |
Pyrazolopyrimidines for treatment of CNS disorders
|
EP0901476A4
(fr)
*
|
1996-03-26 |
2001-08-16 |
Du Pont Pharm Co |
Pyridines et pyrimidines a fusion aryloxy et arylthio et derives de ces dernieres
|
US6107300A
(en)
*
|
1996-03-27 |
2000-08-22 |
Dupont Pharmaceuticals |
Arylamino fused pyrimidines
|
DE69717453T2
(de)
*
|
1996-06-06 |
2003-07-10 |
Otsuka Pharmaceutical Factory, Inc. |
Amid derivate
|
US6060478A
(en)
*
|
1996-07-24 |
2000-05-09 |
Dupont Pharmaceuticals |
Azolo triazines and pyrimidines
|
US6191131B1
(en)
|
1997-07-23 |
2001-02-20 |
Dupont Pharmaceuticals Company |
Azolo triazines and pyrimidines
|
US7094782B1
(en)
|
1996-07-24 |
2006-08-22 |
Bristol-Myers Squibb Company |
Azolo triazines and pyrimidines
|
US6124289A
(en)
*
|
1996-07-24 |
2000-09-26 |
Dupont Pharmaceuticals Co. |
Azolo triazines and pyrimidines
|
US6313124B1
(en)
|
1997-07-23 |
2001-11-06 |
Dupont Pharmaceuticals Company |
Tetrazine bicyclic compounds
|
ES2191183T3
(es)
*
|
1996-08-06 |
2003-09-01 |
Pfizer |
Derivados 6,6- o 6,7-biciclicos que contienen pirido o pirimido sustituidos.
|
US5861398A
(en)
*
|
1996-08-26 |
1999-01-19 |
Alanex Corporation |
Benzoperimidine-carboxylic acids and derivatives thereof
|
TW477787B
(en)
*
|
1996-08-27 |
2002-03-01 |
Pfizer |
Pyrido six-membered nitrogen-containing cyclic ring derivatives having corticotropin releasing factor antagonist activity and pharmaceutical composition containing same
|
WO1998011075A1
(fr)
*
|
1996-09-16 |
1998-03-19 |
Du Pont Pharmaceuticals Company |
Pyrazinones et triazinones ainsi que leurs derives
|
US5723608A
(en)
*
|
1996-12-31 |
1998-03-03 |
Neurogen Corporation |
3-aryl substituted pyrazolo 4,3-d!pyrimidine derivatives; corticotropin-releasing factor receptor (CRF1) specific ligands
|
WO1998035967A2
(fr)
*
|
1997-02-18 |
1998-08-20 |
Neurocrine Biosciences, Inc. |
Antagonistes de recepteurs du crf et procedes associes
|
SE9701398D0
(sv)
*
|
1997-04-15 |
1997-04-15 |
Astra Pharma Prod |
Novel compounds
|
EP1012151B1
(fr)
*
|
1997-09-02 |
2002-08-07 |
Bristol-Myers Squibb Pharma Company |
Pyridines a cycle fusionne et a substitution heterocyclyle, antagonistes du facteur de liberation de la cortitropine (crf), utiles dans le traitement des troubles lies au snc et au stress
|
WO1999045007A1
(fr)
*
|
1998-03-06 |
1999-09-10 |
Janssen Pharmaceutica N.V. |
Pyrazolo[4,3-b]pyridines antagonistes du facteur de liberation de la corticotropine (crf)
|
US6472402B1
(en)
|
1998-04-02 |
2002-10-29 |
Neurogen Corporation |
Aminoalkyl substituted 5,6,7,8-Tetrahydro-9H-Pyridino [2,3-B]indole derivatives
|
AU3375999A
(en)
|
1998-04-02 |
1999-10-25 |
Neurogen Corporation |
Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino(2,3-b)indole and 5,6,7,8-tetrahydro-9h-pyrimidino(4,5-b)indole derivatives: crf1 specific ligands
|
US6984667B2
(en)
*
|
1998-04-08 |
2006-01-10 |
Theta Biomedical Consulting And Development Co. |
Synergistic proteoglycan compositions for inflammatory conditions
|
US6531477B1
(en)
|
1998-10-13 |
2003-03-11 |
Dupont Pharmaceuticals Company |
6-substituted pyrazolo [3,4-d] pyrimidin-4-ones useful as cyclin dependent kinase inhibitors
|
US6559152B2
(en)
*
|
1998-10-13 |
2003-05-06 |
Dupont Pharmaceuticals Company |
6-substituted pyrazolo[3,4-d]pyrimidin-4-ones useful as cyclin dependent kinase inhibitors
|
US6531475B1
(en)
|
1998-11-12 |
2003-03-11 |
Neurocrine Biosciences, Inc. |
CRF receptor antagonists and methods relating thereto
|
DK1129096T3
(da)
|
1998-11-12 |
2003-09-15 |
Neurocrine Biosciences Inc |
CRF-receptorantagonister og fremgangsmåder, der er relateret dertil
|
EP1129091B1
(fr)
*
|
1998-11-12 |
2002-10-02 |
Neurocrine Biosciences, Inc. |
Antagonistes de recepteurs du crf et methodes associees
|
EP1040831A3
(fr)
|
1999-04-02 |
2003-05-02 |
Pfizer Products Inc. |
Utilisation d'antagonistes du facteur de libération de la corticotropine pour la prévention de la mort subite
|
US6387894B1
(en)
|
1999-06-11 |
2002-05-14 |
Pfizer Inc. |
Use of CRF antagonists and renin-angiotensin system inhibitors
|
US6506784B1
(en)
|
1999-07-01 |
2003-01-14 |
3-Dimensional Pharmaceuticals, Inc. |
Use of 1,3-substituted pyrazol-5-yl sulfonates as pesticides
|
US6409988B1
(en)
|
1999-07-01 |
2002-06-25 |
3-Dimensional Pharmaceuticals, Inc. |
Radiolabeled 1-aryl pyrazoles, the synthesis thereof and the use thereof as pest GABA receptor ligands
|
US6518266B1
(en)
|
1999-07-22 |
2003-02-11 |
3-Dimensional Pharmaceuticals |
1- Aryl-3-thioalkyl pyrazoles, the synthesis thereof and the use thereof as insecticides
|
US6432989B1
(en)
|
1999-08-27 |
2002-08-13 |
Pfizer Inc |
Use of CRF antagonists to treat circadian rhythm disorders
|
DE60026155T2
(de)
|
1999-09-30 |
2006-08-10 |
Neurogen Corp., Branford |
Einige alkylendiamin-substituierte heterocyclen
|
WO2001025241A2
(fr)
|
1999-10-06 |
2001-04-12 |
3-Dimensional Pharmaceuticals, Inc. |
1-(2,6-dichloro-4-trifluoromethylphenyl)-pyrazoles fusionnes, leur synthese et utilisation en tant que pesticides
|
CO5271670A1
(es)
|
1999-10-29 |
2003-04-30 |
Pfizer Prod Inc |
Antagonistas del factor de liberacion de corticitropina y composiciones relacionadas
|
US6525067B1
(en)
*
|
1999-11-23 |
2003-02-25 |
Pfizer Inc |
Substituted heterocyclic derivatives
|
TWI271406B
(en)
|
1999-12-13 |
2007-01-21 |
Eisai Co Ltd |
Tricyclic condensed heterocyclic compounds, preparation method of the same and pharmaceuticals comprising the same
|
CA2398956A1
(fr)
*
|
2000-02-14 |
2001-08-16 |
Japan Tobacco Inc. |
Composition pharmaceutique pour la prophylaxie ou le traitement du stress post-operatoire
|
US20060287335A1
(en)
|
2000-11-28 |
2006-12-21 |
Wyeth |
Serotonergic agents for treating sexual dysfunction
|
US20060223824A1
(en)
|
2000-11-28 |
2006-10-05 |
Wyeth |
Serotonergic agents
|
GB0100621D0
(en)
|
2001-01-10 |
2001-02-21 |
Vernalis Res Ltd |
Chemical compounds VI
|
TWI312347B
(en)
|
2001-02-08 |
2009-07-21 |
Eisai R&D Man Co Ltd |
Bicyclic nitrogen-containing condensed ring compounds
|
US7605175B2
(en)
|
2001-03-02 |
2009-10-20 |
Gpc Biotech Ag |
Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
|
WO2002072202A1
(fr)
|
2001-03-13 |
2002-09-19 |
Bristol-Myers Squibb Pharma Company |
4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl) pyrazolo-[1,5-a]-1,3,5-triazine, ses enantiomeres et sels pharmaceutiquement acceptables en tant que ligands du recepteur de la corticoliberine
|
PL214231B1
(pl)
|
2001-04-27 |
2013-07-31 |
Eisai R & D Man Co |
Pochodne pirazolo [1,5-a] pirydyny, kompozycje je zawierajace oraz zastosowanie
|
IL144900A
(en)
|
2001-08-14 |
2013-12-31 |
Neurim Pharma 1991 |
Melatonin and drugs containing it for use in the treatment of primary insomnia, and the manufacture of those drugs
|
US6638981B2
(en)
|
2001-08-17 |
2003-10-28 |
Epicept Corporation |
Topical compositions and methods for treating pain
|
DE10219435A1
(de)
*
|
2002-05-02 |
2003-11-13 |
Bayer Cropscience Ag |
Substituierte Pyrazolo-pyrimidin-4-one
|
TW200400034A
(en)
|
2002-05-20 |
2004-01-01 |
Bristol Myers Squibb Co |
Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors
|
TWI259083B
(en)
*
|
2002-05-24 |
2006-08-01 |
Nat Health Research Institutes |
Anti-enterovirus compounds
|
KR100468352B1
(ko)
*
|
2002-09-24 |
2005-01-27 |
한국과학기술연구원 |
신규 피라졸로피리미딘계 유도체, 그의 제조방법 및 이를 유효성분으로 하는 약학적 조성물
|
US7176216B2
(en)
|
2002-10-22 |
2007-02-13 |
Eisai Co., Ltd. |
7-phenylpyrazolopyridine compounds
|
US7323569B2
(en)
|
2002-10-22 |
2008-01-29 |
Eisai R&D Management Co., Ltd. |
7-phenylpyrazolopyridine compounds
|
JP2006513257A
(ja)
|
2002-12-13 |
2006-04-20 |
ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー |
線維筋痛症および他の障害を処置するためのプレガバリン誘導体
|
NZ540612A
(en)
|
2003-01-14 |
2008-02-29 |
Arena Pharm Inc |
1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
|
JP5064795B2
(ja)
|
2003-04-07 |
2012-10-31 |
アジェニックス ユーエスエー インク. |
サイクリン依存性キナーゼの阻害剤、組成物及びそれに関連する使用
|
WO2004092170A2
(fr)
|
2003-04-09 |
2004-10-28 |
Biogen Idec Ma Inc. |
Triazolotriazines et pyrazolotriazines et leurs procedes de fabrication et d'utilisation
|
US7674791B2
(en)
|
2003-04-09 |
2010-03-09 |
Biogen Idec Ma Inc. |
Triazolopyrazines and methods of making and using the same
|
EP1633756B1
(fr)
|
2003-04-09 |
2008-12-24 |
Biogen Idec MA Inc. |
Antagonistes de recepteur d'adenosine a2a
|
AR045047A1
(es)
|
2003-07-11 |
2005-10-12 |
Arena Pharm Inc |
Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
|
AU2004257267B2
(en)
|
2003-07-14 |
2009-12-03 |
Arena Pharmaceuticals,Inc |
Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
|
US7160888B2
(en)
|
2003-08-22 |
2007-01-09 |
Warner Lambert Company Llc |
[1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
|
JP2007504243A
(ja)
*
|
2003-09-03 |
2007-03-01 |
ニューロジェン・コーポレーション |
5−アリール−ピラゾロ[4,3−d]ピリミジン類、ピリジン類、ピラジン類及び関連化合物
|
GB0326168D0
(en)
*
|
2003-11-10 |
2003-12-17 |
Arrow Therapeutics Ltd |
Chemical compounds
|
GB0327319D0
(en)
*
|
2003-11-24 |
2003-12-24 |
Pfizer Ltd |
Novel pharmaceuticals
|
US7572799B2
(en)
|
2003-11-24 |
2009-08-11 |
Pfizer Inc |
Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
|
KR101155883B1
(ko)
|
2003-12-23 |
2012-06-20 |
아제닉스 유에스에이 인코포레이티드 |
사이클린 의존적 키나제 저해제, 그 조성물 및 그의 용도
|
KR20130116378A
(ko)
*
|
2004-02-17 |
2013-10-23 |
트랜스셉트 파마슈티칼스, 인코포레이티드 |
구강 점막을 가로지르는 수면제 전달용 조성물 및 이의 사용 방법
|
CA2556450C
(fr)
*
|
2004-02-17 |
2013-08-06 |
Transoral Pharmaceuticals, Inc. |
Compositions permettant d'administrer des agents hypnotiques dans la muqueuse orale et methodes d'utilisation
|
US20080287405A1
(en)
*
|
2004-05-14 |
2008-11-20 |
Thannickal Victor J |
Compositions and Methods Relating to Protein Kinase Inhibitors
|
US9512125B2
(en)
|
2004-11-19 |
2016-12-06 |
The Regents Of The University Of California |
Substituted pyrazolo[3.4-D] pyrimidines as anti-inflammatory agents
|
AR056980A1
(es)
*
|
2005-04-22 |
2007-11-07 |
Wyeth Corp |
Derivados de dihidrobenzofurano, composiciones farmaceuticas, y uso de los mismos
|
US20060252825A1
(en)
*
|
2005-04-22 |
2006-11-09 |
Wyeth |
Crystal forms of {[(2r)-7-(2,6-dichlorophenyl)-5-fluoro-2,3-dihydro-1-benzofuran-2-yl]methyl}amine hydrochloride
|
GT200600165A
(es)
*
|
2005-04-22 |
2007-03-14 |
|
Derivados dihidrobenzofuranos y usos de los mismos
|
MX2007013021A
(es)
*
|
2005-04-22 |
2008-01-11 |
Wyeth Corp |
Derivados de benzofuranil-alcanamina y usos de los mismos como agonistas de 5-ht2c.
|
WO2006128022A2
(fr)
*
|
2005-05-25 |
2006-11-30 |
Transcept Pharmaceuticals, Inc. |
Compositions solides et techniques de traitement d'insomnie survenant au milieu de la nuit
|
US20070287740A1
(en)
*
|
2005-05-25 |
2007-12-13 |
Transcept Pharmaceuticals, Inc. |
Compositions and methods of treating middle-of-the night insomnia
|
US20070225322A1
(en)
*
|
2005-05-25 |
2007-09-27 |
Transoral Pharmaceuticals, Inc. |
Compositions and methods for treating middle-of-the night insomnia
|
WO2006126718A1
(fr)
*
|
2005-05-27 |
2006-11-30 |
Tanabe Seiyaku Co., Ltd. |
Dérivé de pyrazolopyrimidine
|
TW200800959A
(en)
|
2005-06-10 |
2008-01-01 |
Wyeth Corp |
Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor
|
CA2611979A1
(fr)
*
|
2005-06-15 |
2006-12-21 |
Pfizer Limited |
Arylpyrazoles substitues
|
WO2007024680A1
(fr)
|
2005-08-22 |
2007-03-01 |
Amgen Inc. |
Composes de pyrazolopyridine et de pyrazolopyrimidine utilises comme modulateurs d'enzymes kinases
|
CA2644662A1
(fr)
*
|
2006-03-24 |
2007-10-04 |
Wyeth |
Nouvelles combinaisons therapeutiques pour le traitement de la depression
|
GB2453058A
(en)
|
2006-04-04 |
2009-03-25 |
Univ California |
Kinase antagonists
|
EP2004656B1
(fr)
|
2006-04-07 |
2013-07-10 |
Boehringer Ingelheim International GmbH |
Thiénopyrimidines ayant une activité inhibitrice mnk1/mnk2 utilisées dans des compositions pharmaceutiques
|
DE102006029074A1
(de)
|
2006-06-22 |
2007-12-27 |
Friedrich-Schiller-Universität Jena |
4-Amino-3-arylamino-6-arylpyrazolo[3,4-d]pyrimidin-Derivate, Verfahren zu ihrer Herstellung und deren Verwendung als antivirale Wirkstoffe
|
EP1889847A1
(fr)
|
2006-07-10 |
2008-02-20 |
DeveloGen Aktiengesellschaft |
Dérivés de pyrrolopyrimidine pour applications pharmaceutiques
|
EP2532235A1
(fr)
*
|
2006-09-22 |
2012-12-12 |
Pharmacyclics, Inc. |
Inhibiteurs de la tyrosine kinase de bruton
|
TW200901974A
(en)
|
2007-01-16 |
2009-01-16 |
Wyeth Corp |
Compounds, compositions, and methods of making and using them
|
US20110160232A1
(en)
|
2007-10-04 |
2011-06-30 |
Pingda Ren |
Certain chemical entities and therapeutic uses thereof
|
EP2219649A2
(fr)
*
|
2007-11-22 |
2010-08-25 |
Boehringer Ingelheim International Gmbh |
Utilisation d'inhibiteurs de mnk pour le traitement de la maladie d'alzheimer
|
US8193182B2
(en)
*
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
KR101897881B1
(ko)
|
2008-01-04 |
2018-09-12 |
인텔리카인, 엘엘씨 |
특정 화학 물질, 조성물 및 방법
|
CA2716080C
(fr)
|
2008-02-20 |
2016-12-13 |
Targia Pharmaceuticals |
Compositions pharmaceutiques actives sur le snc et methodes d'utilisation
|
WO2009114870A2
(fr)
|
2008-03-14 |
2009-09-17 |
Intellikine, Inc. |
Inhibiteurs de kinases, et procédés d’utilisation associés
|
WO2009114874A2
(fr)
|
2008-03-14 |
2009-09-17 |
Intellikine, Inc. |
Inhibiteurs de kinases (benzothiazole) et procédés d’utilisation associés
|
SI2266990T1
(sl)
|
2008-04-15 |
2013-01-31 |
Eisai R&D Management Co. Ltd. |
Spojina 3-fenilpirazolo(5,1-b)tiazola
|
EP2291181B9
(fr)
|
2008-04-18 |
2013-09-11 |
University College Dublin National University Of Ireland, Dublin |
Utilisation de la captodiamine pour le traitement des symptômes de la dépression
|
US20110224223A1
(en)
|
2008-07-08 |
2011-09-15 |
The Regents Of The University Of California, A California Corporation |
MTOR Modulators and Uses Thereof
|
EP2313414B1
(fr)
|
2008-07-08 |
2015-11-04 |
Intellikine, LLC |
Inhibiteurs de kinases et procédés d'utilisation
|
KR20110045019A
(ko)
|
2008-08-26 |
2011-05-03 |
베링거 인겔하임 인터내셔날 게엠베하 |
약제학적 조성물을 위한 티에노피리미딘
|
CA2738429C
(fr)
|
2008-09-26 |
2016-10-25 |
Intellikine, Inc. |
Inhibiteurs heterocycliques de kinases
|
DK2358720T3
(en)
|
2008-10-16 |
2016-06-06 |
Univ California |
Heteroarylkinaseinhibitorer fused-ring
|
US8476431B2
(en)
|
2008-11-03 |
2013-07-02 |
Itellikine LLC |
Benzoxazole kinase inhibitors and methods of use
|
JP5789252B2
(ja)
|
2009-05-07 |
2015-10-07 |
インテリカイン, エルエルシー |
複素環式化合物およびその使用
|
AR078521A1
(es)
|
2009-10-08 |
2011-11-16 |
Eisai R&D Man Co Ltd |
Compuesto pirazolotiazol
|
US8980899B2
(en)
|
2009-10-16 |
2015-03-17 |
The Regents Of The University Of California |
Methods of inhibiting Ire1
|
AU2011219764A1
(en)
|
2010-02-26 |
2012-08-16 |
Boehringer Ingelheim International Gmbh |
Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions
|
UY33241A
(es)
|
2010-02-26 |
2011-09-30 |
Boehringer Ingelheim Int |
?Tienopirimidinas que contienen heterocicloalquilo para composiciones farmacéuticas?.
|
TW201141872A
(en)
|
2010-02-26 |
2011-12-01 |
Boehringer Ingelheim Int |
Cycloalkyl containing thienopyrimidines for pharmaceutical compositions
|
AR080711A1
(es)
*
|
2010-03-31 |
2012-05-02 |
Lilly Co Eli |
Compuesto de piperazin-purina composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para el tratamiento o prevencion del dolor
|
ES2593256T3
(es)
|
2010-05-21 |
2016-12-07 |
Infinity Pharmaceuticals, Inc. |
Compuestos químicos, composiciones y métodos para las modulaciones de cinasas
|
EP2619198A1
(fr)
|
2010-09-22 |
2013-07-31 |
Arena Pharmaceuticals, Inc. |
Modulateurs du récepteur gpr119 et traitement des troubles qui lui sont liés
|
EP2637669A4
(fr)
|
2010-11-10 |
2014-04-02 |
Infinity Pharmaceuticals Inc |
Composés hétérocycliques et utilisations de ceux-ci
|
ES2637113T3
(es)
|
2011-01-10 |
2017-10-10 |
Infinity Pharmaceuticals, Inc. |
Procedimientos para preparar isoquinolinonas y formas sólidas de isoquinolinonas
|
TWI592411B
(zh)
|
2011-02-23 |
2017-07-21 |
英特爾立秦有限責任公司 |
激酶抑制劑之組合及其用途
|
TWI565709B
(zh)
|
2011-07-19 |
2017-01-11 |
英菲尼提製藥股份有限公司 |
雜環化合物及其用途
|
CN103930422A
(zh)
|
2011-07-19 |
2014-07-16 |
无限药品股份有限公司 |
杂环化合物及其用途
|
CN103957918A
(zh)
*
|
2011-08-11 |
2014-07-30 |
因特利凯有限责任公司 |
激酶抑制剂多晶型物
|
WO2013032591A1
(fr)
|
2011-08-29 |
2013-03-07 |
Infinity Pharmaceuticals Inc. |
Composés hétérocycliques et leurs utilisations
|
MX370814B
(es)
|
2011-09-02 |
2020-01-08 |
Univ California |
Pirazolo[3,4-d]pirimidinas sustituidas y usos de las mismas.
|
RU2014118953A
(ru)
*
|
2011-10-14 |
2015-11-20 |
Дритте Патентпортфолио Бетайлигунгсгезельшафт Мбх Унд Ко. Кг |
4-АМИНО-3-ФЕНИЛАМИНО-6-ФЕНИЛПИРАЗОЛО[3,4-d] ПИРИМИДИНОВЫЕ ПРОИЗВОДНЫЕ, ИХ ПРОИЗВОДСТВО И ИСПОЛЬЗОВАНИЕ В КАЧЕСТВЕ АНТИВИРУСНЫХ СРЕДСТВ
|
DE102012004736A1
(de)
|
2011-10-20 |
2013-04-25 |
Dritte Patentportfolio Beteiligungsgesellschaft Mbh & Co.Kg |
4-Amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidin-Derivate und deren Verwendung als antivirale Wirkstoffe
|
US8940742B2
(en)
|
2012-04-10 |
2015-01-27 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
US8828998B2
(en)
|
2012-06-25 |
2014-09-09 |
Infinity Pharmaceuticals, Inc. |
Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
|
CN104995192A
(zh)
|
2012-09-26 |
2015-10-21 |
加利福尼亚大学董事会 |
Ire1的调节
|
US10154988B2
(en)
|
2012-11-14 |
2018-12-18 |
The Johns Hopkins University |
Methods and compositions for treating schizophrenia
|
US9481667B2
(en)
|
2013-03-15 |
2016-11-01 |
Infinity Pharmaceuticals, Inc. |
Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
|
WO2015051241A1
(fr)
|
2013-10-04 |
2015-04-09 |
Infinity Pharmaceuticals, Inc. |
Composés hétérocycliques et leurs utilisations
|
ES2900806T3
(es)
|
2013-10-04 |
2022-03-18 |
Infinity Pharmaceuticals Inc |
Compuestos heterocíclicos y usos de los mismos
|
JP6701088B2
(ja)
|
2014-03-19 |
2020-05-27 |
インフィニティー ファーマシューティカルズ, インコーポレイテッド |
Pi3k−ガンマ媒介障害の治療で使用するための複素環式化合物
|
US20150320755A1
(en)
|
2014-04-16 |
2015-11-12 |
Infinity Pharmaceuticals, Inc. |
Combination therapies
|
US9708348B2
(en)
|
2014-10-03 |
2017-07-18 |
Infinity Pharmaceuticals, Inc. |
Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof
|
EP4445956A2
(fr)
|
2015-01-06 |
2024-10-16 |
Arena Pharmaceuticals, Inc. |
Composé pour le traitement des affections associés à s1p1-récepteur
|
WO2016209809A1
(fr)
|
2015-06-22 |
2016-12-29 |
Arena Pharmaceuticals, Inc. |
Sel l-arginine cristallin d'acide (r)-2-(7-(4-cyclopentyl-3-(trifluorométhyl)benzyloxy)-1,2,3,4-tétrahydrocyclo-penta[b]indol-3-yl)acétique (composé 1) pour une utilisation dans des troubles associés au récepteur de s1p1
|
US10160761B2
(en)
|
2015-09-14 |
2018-12-25 |
Infinity Pharmaceuticals, Inc. |
Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the same
|
WO2017161116A1
(fr)
|
2016-03-17 |
2017-09-21 |
Infinity Pharmaceuticals, Inc. |
Isotopologues de composés isoquinolinone et quinazolinone et leurs utilisations comme inhibiteurs de la kinase pi3k
|
US10919914B2
(en)
|
2016-06-08 |
2021-02-16 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
EP3474856B1
(fr)
|
2016-06-24 |
2022-09-14 |
Infinity Pharmaceuticals, Inc. |
Therapies combinées
|
WO2018081451A1
(fr)
*
|
2016-10-26 |
2018-05-03 |
Indiana University Research And Technology Corporation |
Inhibiteurs de la protéine arginine méthyltransférase 5 (prmt5) de type petites molécules, et méthodes de traitement
|
US10729693B2
(en)
*
|
2018-03-02 |
2020-08-04 |
Ponce Medical School Foundation, Inc. |
Compositions and methods for the treatment of endometriosis
|
CN110734439A
(zh)
*
|
2019-11-07 |
2020-01-31 |
中国药科大学 |
一种母核为吡唑并[3,4-d]嘧啶类化合物及其制备方法
|